Pulmonary · PANCE / PANRE

Acute Respiratory Distress Syndrome (ARDS)

Acute non-cardiogenic pulmonary edema with diffuse alveolar damage and severe hypoxemia.

Also known as: ARDS, acute respiratory distress syndrome, noncardiogenic pulmonary edema, Berlin criteria

Overview

Acute, diffuse inflammatory lung injury causing increased pulmonary vascular permeability and alveolar edema, leading to hypoxemic respiratory failure not fully explained by cardiac failure or volume overload. Defined by the Berlin criteria (2012) and updated by the global definition (2023).

Epidemiology

Affects ~10% of ICU patients and ~25% of mechanically ventilated patients (LUNG SAFE study). Mortality 35-46% depending on severity. Common in sepsis, pneumonia (including SARS-CoV-2), and trauma populations.

Try two board-style Acute Respiratory Distress Syndrome questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1PulmonaryMedium
A 45-year-old man develops acute dyspnea, bilateral pulmonary infiltrates, and hypoxemia (PaO₂/FiO₂ ratio 180) within 4 hours of a packed red blood cell transfusion. He is normotensive, BNP is normal, and there is no jugular venous distention or peripheral edema. Which of the following is the most likely diagnosis?
  • AAcute septic transfusion reaction
  • BAcute hemolytic transfusion reaction
  • CTransfusion-related acute lung injury
  • DTransfusion-associated circulatory overload
  • EAcute anaphylactic transfusion reaction
Reveal answer & full explanation
Correct answer: C — Transfusion-related acute lung injury
  • AAcute septic transfusion reaction
  • BAcute hemolytic transfusion reaction
  • CTransfusion-related acute lung injury✓
  • DTransfusion-associated circulatory overload
  • EAcute anaphylactic transfusion reaction

Why Transfusion-related acute lung injury is correct

  • TRALI is non-cardiogenic pulmonary edema that begins during or within 6 hours of a transfusion, fitting onset 4 hours after transfusion here
  • Donor anti-leukocyte (anti-HLA/anti-HNA) antibodies activate recipient neutrophils, causing pulmonary capillary leak with bilateral infiltrates and hypoxemia
  • The normal BNP, normotension, and absence of jugular venous distention or peripheral edema confirm a non-cardiogenic, non-overload process
  • Management is supportive (oxygen, lung-protective ventilation if needed); diuretics and steroids are not indicated

Why the others are wrong

  • Acute anaphylactic transfusion reaction — produces urticaria, bronchospasm, angioedema, and hypotension within minutes, not bilateral infiltrates with hypoxemia (buzzword-matching "transfusion reaction")
  • Transfusion-associated circulatory overload — also causes dyspnea after transfusion but is cardiogenic, with hypertension, elevated BNP, and edema that are absent here (premature closure on the most common transfusion pulmonary reaction)
  • Acute septic transfusion reaction — bacterial contamination of the unit causes high fever, rigors, and hypotension progressing to shock, not a normotensive picture of isolated hypoxemia with bilateral infiltrates (buzzword-matching another acute transfusion complication)
  • Acute hemolytic transfusion reaction — intravascular hemolysis from ABO-incompatible blood causes fever, chills, flank or back pain, hypotension, and hemoglobinuria, often progressing to DIC and acute kidney injury, not a normotensive picture of bilateral infiltrates with isolated hypoxemia (assuming every acute transfusion reaction is hemolytic)
Question 2PulmonaryMedium
A 38-year-old female who is 32 weeks pregnant develops acute severe dyspnea and hypoxemia (SpO2 84%) requiring intubation. Her chest X-ray shows bilateral alveolar infiltrates. Echo shows no cardiac pathology. She had no prior lung disease. Her PaO2/FiO2 ratio is 98. She received a blood transfusion 4 hours ago for placenta previa. Which of the following is the most likely diagnosis?
  • ATransfusion-related acute lung injury
  • BAnaphylactic transfusion reaction
  • CAmniotic fluid embolism
  • DAcute pulmonary embolism
  • ECommunity-acquired pneumonia
Reveal answer & full explanation
Correct answer: A — Transfusion-related acute lung injury
  • ATransfusion-related acute lung injury✓
  • BAnaphylactic transfusion reaction
  • CAmniotic fluid embolism
  • DAcute pulmonary embolism
  • ECommunity-acquired pneumonia

Why transfusion-related acute lung injury is correct

  • All diagnostic criteria are met: acute onset within 6 hours of transfusion (symptoms began 4 hours after transfusion)
  • Bilateral radiographic infiltrates are present
  • Hypoxemia is confirmed by a PaO2/FiO2 ratio of 98 (below 300) and SpO2 of 84% (below 90%)
  • There was no pre-existing acute lung injury before transfusion and no evidence of circulatory overload
  • Two-hit model: pregnancy and surgery prime the pulmonary endothelium, then donor anti-HLA or anti-HNA antibodies activate primed neutrophils, causing non-cardiogenic edema
  • It is the most common cause of transfusion-associated mortality

Why the others are wrong

  • Acute pulmonary embolism — right-concept-wrong-radiograph; pregnancy is a hypercoagulable state, but PE characteristically leaves the chest film clear or shows only focal atelectasis rather than bilateral alveolar infiltrates, and it has no temporal link to the transfusion
  • Community-acquired pneumonia — anchoring on bilateral infiltrates; it would not arise within hours of transfusion and no fever prodrome is described
  • Amniotic fluid embolism — right-concept-wrong-setting; it occurs during or immediately after delivery or amniocentesis, not 4 hours after a blood transfusion
  • Anaphylactic transfusion reaction — right-trigger-wrong-reaction; the recent transfusion and the need for intubation suggest an allergic reaction, but transfusion anaphylaxis (classically an IgA-deficient recipient with anti-IgA antibodies) begins within minutes of starting the transfusion with hypotension, bronchospasm, urticaria, or angioedema, not as bilateral alveolar infiltrates with severe hypoxemia 4 hours later

Additional high-yield points

  • Treatment is supportive: lung-protective ventilation and avoidance of diuretics
  • Most patients recover within 48–96 hours
  • Distinguish from transfusion-associated circulatory overload (TACO), which is cardiogenic edema that responds to diuretics; TRALI does not
  • High-risk donors are multiparous women sensitized to HLA antigens, now excluded from donating plasma

That's 2. Get 7,700+ more.

Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial →
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Acute Respiratory Distress Syndrome (ARDS) outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Direct lung injury: pneumonia (bacterial, viral including COVID-19, fungal), aspiration, pulmonary contusion, near-drowning, inhalation injury
  • Indirect lung injury: sepsis (most common overall), severe trauma, massive transfusion (TRALI), pancreatitis, burns, drug overdose, post-cardiopulmonary bypass
  • Older age, chronic alcohol use, hypoalbuminemia, smoking, obesity

Pathophysiology

Inflammatory cascade injures pulmonary capillary endothelium and alveolar epithelium → protein-rich edema floods alveoli, surfactant dysfunction, hyaline membrane formation → diffuse alveolar damage. Stages: exudative (0-7 days), proliferative (7-21 days), fibrotic (after 3 weeks). V/Q mismatch and intrapulmonary shunt drive severe hypoxemia refractory to supplemental O2 alone.

Clinical presentation

Symptoms

  • Rapidly progressive dyspnea (within 1 week of inciting insult)
  • Tachypnea, productive or non-productive cough
  • Symptoms of underlying cause: fever, hypotension, trauma history

Signs / physical exam

  • Tachypnea, hypoxia (often refractory to supplemental O2)
  • Diffuse crackles bilaterally
  • Use of accessory muscles, retractions
  • Findings of underlying etiology — sepsis features, trauma findings

Differential diagnosis

  • Cardiogenic pulmonary edema — Elevated PCWP, BNP elevation, cardiomegaly, response to diuresis; echo shows LV dysfunction
  • Diffuse alveolar hemorrhage — Hemoptysis, dropping hematocrit, serial BAL progressively bloodier; vasculitis, anticoagulation, cocaine
  • Acute interstitial pneumonia (Hamman-Rich) — Idiopathic ARDS-like picture; bilateral GGOs; diagnosis of exclusion
  • Acute eosinophilic pneumonia — Days of fevers, infiltrates; BAL eosinophilia >25%; rapid response to steroids
  • Cryptogenic organizing pneumonia (COP) — Subacute course, peripheral consolidations; biopsy with organizing pneumonia; steroid-responsive
  • Hypersensitivity pneumonitis (acute) — Exposure history (birds, mold); resolves with antigen avoidance and steroids

Diagnostic workup

Diagnostic criteria

Berlin Criteria (2012): (1) acute onset ≤1 week of insult or new symptoms, (2) bilateral opacities on chest imaging, (3) respiratory failure not fully explained by cardiac failure/fluid overload, (4) impaired oxygenation with PEEP ≥5 cm H2O — mild PaO2/FiO2 >200 to ≤300, moderate >100 to ≤200, severe ≤100. 2023 global definition extends to high-flow nasal O2 ≥30 L/min, accepts SpO2/FiO2 ≤315 (if SpO2 ≤97%) and lung ultrasound, and adapts criteria for resource-limited settings.

Labs

  • ABG — severe hypoxemia, often with respiratory alkalosis (early) progressing to acidosis
  • CBC, BMP, LFTs, lactate, lipase, blood and urine cultures
  • BNP and echocardiography to exclude cardiogenic edema
  • Procalcitonin if bacterial source uncertain
  • Respiratory viral PCR (including SARS-CoV-2, influenza)
  • Bronchoalveolar lavage if etiology unclear or to evaluate for atypical infection, eosinophilic pneumonia, or DAH

Imaging

  • Chest radiograph: bilateral opacities not fully explained by effusion, atelectasis, or nodules
  • CT chest (often shows heterogeneous dependent consolidation with anterior aeration — 'baby lung')
  • Bedside echocardiography (transthoracic): exclude LV dysfunction; identify RV strain

Diagnostic algorithm

Severity (Berlin)PaO2/FiO2 with PEEP ≥5Mortality
Mild>200 to ≤300~27%
Moderate>100 to ≤200~32%
Severe≤100~45%
Berlin definition severity stratification of ARDS and associated mortality (Ranieri 2012).

Treatment

First-line

  • Treat underlying cause (source control, antibiotics for sepsis, supportive care)
  • Lung-protective mechanical ventilation (ARDSnet protocol, ARMA trial), which lowers mortality by limiting overdistension and cyclic stretch of the small aerated 'baby lung' (less ventilator-induced lung injury), not by improving oxygenation:
  • Low tidal volume 6 mL/kg ideal body weight (start 8 then titrate down)
  • Plateau pressure ≤30 cm H2O
  • PEEP titrated to maintain oxygenation (lower or higher PEEP-FiO2 tables); PEEP and proning, not low tidal volume, recruit collapsed alveoli
  • Permissive hypercapnia (pH ≥7.20 acceptable): smaller breaths raise PaCO2 and dead-space fraction
  • Conservative fluid strategy after initial resuscitation (FACTT trial)
  • Prone positioning ≥16 hours/day for PaO2/FiO2 <150 (PROSEVA trial) — proven mortality benefit
  • Neuromuscular blockade (cisatracurium) — selective use in early severe ARDS (ACURASYS supported; ROSE was negative; reserve for severe dyssynchrony)
  • Adjuncts for refractory hypoxemia: inhaled pulmonary vasodilators (nitric oxide, epoprostenol) — improve oxygenation but no mortality benefit

Second-line / adjunct

  • Veno-venous ECMO for severe ARDS with refractory hypoxemia/hypercapnia despite optimization (EOLIA, post-hoc Bayesian analysis suggests benefit) — refer to experienced center
  • Corticosteroids: dexamethasone 20 mg/day × 5 d then 10 mg × 5 d in moderate-severe ARDS (DEXA-ARDS); 6 mg/day in COVID-19 ARDS (RECOVERY trial)
  • Avoid: routine high-dose steroids late (>14 days), beta-2 agonists, statins, surfactant — none have improved outcomes in adult ARDS
  • Early mobilization, daily SBT and sedation interruption to limit ICU complications

Complications

  • Refractory hypoxemia, multiorgan failure
  • Ventilator-induced lung injury (volutrauma, barotrauma, atelectrauma, biotrauma)
  • ICU-acquired weakness, post-intensive-care syndrome (PICS): cognitive, psychiatric, physical sequelae
  • Pulmonary fibrosis (fibrotic ARDS) with chronic pulmonary dysfunction
  • Ventilator-associated pneumonia, line infections

PANCE pearls

  • ARDSnet low-tidal-volume (6 mL/kg IBW) ventilation is the only proven mortality-reducing intervention besides prone positioning and dexamethasone (COVID-ARDS).
  • Prone positioning ≥16 h/day reduces mortality in moderate-severe ARDS (PROSEVA) — implement early.
  • PaO2/FiO2 ratios are measured on PEEP ≥5 — without PEEP, severity grading does not apply.
  • Steroids are useful in COVID-19 ARDS (RECOVERY) and may benefit other moderate-severe ARDS (DEXA-ARDS); avoid in influenza ARDS unless other indication.
  • ECMO is rescue therapy for refractory hypoxemia — early referral to ECMO centers improves outcomes.

References

  • ARMA / ARDSnet — Ventilation with Lower Tidal Volumes for ARDS (ARDS Network, NEJM 2000)
  • PROSEVA — Prone Positioning in Severe Acute Respiratory Distress Syndrome (Guérin et al., NEJM 2013)
  • Berlin Definition — Acute Respiratory Distress Syndrome: The Berlin Definition (Ranieri et al., JAMA 2012)
  • RECOVERY — Dexamethasone in Hospitalized Patients with COVID-19 (Horby et al., NEJM 2021)

Practice Pulmonary questions on FirstPassPA

Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start your 7-day free trial → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.